Current filters:  
China
Healthcare
Food and Drugs Law
China
Kangxin
On October 17, 2020, the third draft of the 4th revision of the Chinese Patent Law was approved by the Standing Committee of the National People's Congress and will come into force on June 1, 2021.
HFG Law & Intellectual Property
October started with a week of celebrations for the 75th anniversary of People's Republic of China and a new GossIP number!
Kangxin
2020年10月17日、第四次特許法改正案が全国人民代表大会常務委員会の審議で通過し、2021年6月1日から施行することになりました。
Toby Mak
First pre-trial injunction granted for a drug patent in China: Astellas Pharma v Zhejiang Hisun Pharmaceutical.
Arnold & Porter
China has proposed a new rule framing a drug patent linkage system that will have significant impact on multinational pharmaceutical companies doing business in China
Morrison & Foerster LLP
On July 3, 2020, China's National People's Congress published the second draft of the latest amendment to China's Patent Law (the "Draft Amendment") for public comments, which were allowed to be submitted by August 16, 2020.
HFG Law & Intellectual Property
With decision issued on July 29 2020 and notified to the parties on August 11 2020 Shanghai Yangpu District People's Court has recognized Fabbri's packaging -bearing the famous blue-and-white "faentino" decoration- ...
Ropes & Gray LLP
The most recent amendment to the Chinese Patent Law describes the general principles of patent linkage, but lacks operational details.
Toby Mak
This Method is drafted by China's National Medical Products Administration in conjunction with the China National IP Administration, and was published for public's comments on 11 September 2020 in the link below.
HFG Law & Intellectual Property
Here below is a brief introduction to the "Measures for the Supervision and Administration of Food Labeling (Draft for Comment)" (abbr. Draft for Comment).
HFG Law & Intellectual Property
The Thirteenth National People's Congress has released its second draft amendments to the Patent Law for comment on July 3, 2020, which is open for public comments until August 16, 2020.
CCPIT Patent & Trademark Law Office
On June 20, 2020, the Standing Committee of the National People's Congress (NPC) published its 2020 version of draft amendments to Patent Law (2020 version) for comment.
HFG Law & Intellectual Property
A series of drafts for comments of laws and regulations have been released by relevant government authorities recently and we prepared a series of "brief" on these topics.
China Sinda Intellectual Property Ltd
The Beijing IP Court has issued a preliminary injunction against a patent infringer in a pharmaceutical case earlier this year.
China Sinda Intellectual Property Ltd
China's National People's Congress (NPC) has recently published an updated Draft of Proposed Amendment to Chinese Patent Law.
Global Advertising Lawyers Alliance (GALA)
In our previous article, Code of Conduct for Online Livestreaming Marketing Issued in China, we summarized the key points of the Code of Conduct for Online Livestreaming Marketing in China issued by the CAA on June 24, 2020 ...
Arnold & Porter
Multinational pharmaceutical and medical device companies conducting clinical trials in China have been facing new challenges in the year since the Regulation on Human Genetic Resources...
Kangxin
2020년 6월 28일, 중국 제약산업협회(医药物资协会)는 ‘2019년 중국 제약 지식재산권 산업 발전 현황 보고(2019年度中国医药知识产权行业发展状况报告)'를 발표함
Ropes & Gray LLP
On July 3, 2020, the Standing Committee of the National People's Congress published the second draft amendment to the Patent Law (the "Second Draft Amendment"), ...
Ropes & Gray LLP
On July 3, 2020, the Standing Committee of the National People's Congress published the second draft amendment to the Patent Law (the "Second Draft Amendment"), soliciting public...
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Tools
Font Size:
Translation
Mondaq Social Media